Balyasny Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-19,189
| Closed | -$5.72K | – | 2356 |
|
2023
Q2 | $5.72K | Buy |
+19,189
| New | +$5.72K | ﹤0.01% | 1797 |
|
2022
Q2 | – | Sell |
-14,715
| Closed | -$142K | – | 2828 |
|
2022
Q1 | $142K | Sell |
14,715
-385,285
| -96% | -$3.72M | ﹤0.01% | 1734 |
|
2021
Q4 | $3.97M | Hold |
400,000
| – | – | 0.01% | 775 |
|
2021
Q3 | $3.96M | Hold |
400,000
| – | – | 0.02% | 744 |
|
2021
Q2 | $3.92M | Hold |
400,000
| – | – | 0.02% | 706 |
|
2021
Q1 | $3.88M | Buy |
+400,000
| New | +$3.88M | 0.02% | 654 |
|